Found: 14
Select item for more details and to access through your institution.
The Glucagon-Like Peptide 1 Receptor Agonist Exenatide Inhibits Small Intestinal Motility, Flow, Transit, and Absorption of Glucose in Healthy Subjects and Patients With Type 2 Diabetes: A Randomized Controlled Trial.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Effects of Sitagliptin on Glycemia, Incretin Hormones, and Antropyloroduodenal Motility in Response to Intraduodenal Glucose Infusion in Healthy Lean and Obese Humans and Patients With Type 2 Diabetes Treated With or Without Metformin.
- Published in:
- Diabetes, 2014, v. 63, n. 8, p. 2776, doi. 10.2337/db13-1627
- By:
- Publication type:
- Article
Acute effects of the glucagon-like peptide-1 receptor agonist, exenatide, on blood pressure and heart rate responses to intraduodenal glucose infusion in type 2 diabetes.
- Published in:
- Diabetes & Vascular Disease Research, 2017, v. 14, n. 1, p. 59, doi. 10.1177/1479164116666761
- By:
- Publication type:
- Article
Randomised comparison of intravenous and subcutaneous routes of glucagon‐like peptide‐1 administration for lowering plasma glucose in hyperglycaemic subjects with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 9, p. 3897, doi. 10.1111/dom.15736
- By:
- Publication type:
- Article
A whey/guar "preload" improves postprandial glycaemia and glycated haemoglobin levels in type 2 diabetes: A 12‐week, single‐blind, randomized, placebo‐controlled trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 4, p. 930, doi. 10.1111/dom.13604
- By:
- Publication type:
- Article
Impact of the timing of metformin administration on glycaemic and glucagon-like peptide-1 responses to intraduodenal glucose infusion in type 2 diabetes: a double-blind, randomised, placebo-controlled, crossover study.
- Published in:
- Diabetologia, 2024, v. 67, n. 7, p. 1260, doi. 10.1007/s00125-024-06131-6
- By:
- Publication type:
- Article
Small Intestinal Glucose Delivery Affects the Lowering of Blood Glucose by Acute Vildagliptin in Type 2 Diabetes.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Effects of Taurocholic Acid on Glycemic, Glucagon-like Peptide-1, and Insulin Responses to Small Intestinal Glucose Infusion in Healthy Humans.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Effects of Vildagliptin and Metformin on Blood Pressure and Heart Rate Responses to Small Intestinal Glucose in Type 2 Diabetes.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A Protein Preload Enhances the Glucose-Lowering Efficacy of Vildagliptin in Type 2 Diabetes.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Artificial Sweeteners Have No Effect on Gastric Emptying, Glucagon-Like Peptide-1, or Glycemia After Oral Glucose in Healthy Humans.
- Published in:
- Diabetes Care, 2013, v. 36, n. 12, p. e202, doi. 10.2337/dc13-0958
- By:
- Publication type:
- Article
Effects of a D-Xylose Preload With or Without Sitagliptin on Gastric Emptying, Glucagon-Like Peptide-1, and Postprandial Glycemia in Type 2 Diabetes.
- Published in:
- Diabetes Care, 2013, v. 36, n. 7, p. 1913, doi. 10.2337/dc12-2294
- By:
- Publication type:
- Article
Erratum. Effects of Sustained Treatment With Lixisenatide on Gastric Emptying and Postprandial Glucose Metabolism in Type 2 Diabetes: A Randomized Controlled Trial. Diabetes Care 2020;43:1813-1821.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Effects of Sustained Treatment With Lixisenatide on Gastric Emptying and Postprandial Glucose Metabolism in Type 2 Diabetes: A Randomized Controlled Trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article